Quarterly report · Q2
3645.TEDINET S100SMIQ
Period2023-06-01 → 2023-11-30
Filed2024-01-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.3bn | 2023-06-01 → 2023-11-30 | Cons. | Net sales |
| Revenue | ¥4.5bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.0bn | 2022-06-01 → 2022-11-30 | Cons. | Net sales |
| Operating income | ¥170m | 2023-06-01 → 2023-11-30 | Cons. | Operating income |
| Operating income | ¥178m | 2022-06-01 → 2022-11-30 | Cons. | Operating income |
| Ordinary income | ¥194m | 2023-06-01 → 2023-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥432m | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥205m | 2022-06-01 → 2022-11-30 | Cons. | Ordinary income |
| Profit before tax | ¥192m | 2023-06-01 → 2023-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥207m | 2022-06-01 → 2022-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥116m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥116m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥116m | 2022-06-01 → 2022-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥126m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss |
| Net income | ¥130m | 2022-06-01 → 2022-11-30 | Cons. | Profit loss |
| Total assets | ¥3.6bn | at 2023-11-30 | Cons. | Assets |
| Total assets | ¥3.5bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥3.4bn | at 2022-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2023-11-30 | Cons. | Liabilities |
| Total liabilities | ¥1.5bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.0bn | at 2023-11-30 | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2022-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2023-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2023-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.4bn | at 2023-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2023-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2022-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-05-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥131m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥429m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥59m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥14m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥62m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥32m | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥14m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥18m | 2022-06-01 → 2023-05-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥906,000 | 2022-06-01 → 2022-11-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥12.8 | 2023-06-01 → 2023-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.39 | 2023-09-01 → 2023-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.97 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13.09 | 2022-06-01 → 2022-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.36 | 2022-09-01 → 2022-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 56.4% | at 2023-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.3% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.8% | at 2022-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-06-01 → 2023-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-06-01 → 2023-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-06-01 → 2023-11-30 | ¥2m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥562m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥562m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥315m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥70m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥70m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥7m |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥1.7bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥1.7bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥68m |
| —segment total | revenue | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| —segment total | revenue external | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| —segment total | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| —segment total | segment profit | 2023-06-01 → 2023-11-30 | ¥390m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-06-01 → 2023-11-30 | ¥392m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-06-01 → 2022-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-06-01 → 2022-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-06-01 → 2022-11-30 | ¥2m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥499m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥499m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥2,000 |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥297m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥83m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥83m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥12,000 |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥25m |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue | 2022-06-01 → 2022-11-30 | ¥1.4bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue external | 2022-06-01 → 2022-11-30 | ¥1.4bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥213,000 |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | segment profit | 2022-06-01 → 2022-11-30 | ¥51m |
| —segment total | revenue | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| —segment total | revenue external | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| —segment total | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥228,000 |
| —segment total | segment profit | 2022-06-01 → 2022-11-30 | ¥374m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2022-11-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-06-01 → 2022-11-30 | ¥228,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2022-11-30 | ¥376m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 493
| Item | Context | Value | Unit |
|---|---|---|---|
| Non operating income | Prior1YTDDuration | 28822000 | JPY |
| Non operating income | CurrentYTDDuration | 27836000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 1528000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 2170000 | JPY |
| Provision of allowance for doubtful accounts noe | Prior1YTDDuration | － | JPY |
| Provision of allowance for doubtful accounts noe | CurrentYTDDuration | 1376000 | JPY |
| Other noe | Prior1YTDDuration | 17000 | JPY |
| Other noe | CurrentYTDDuration | 28000 | JPY |
| Non operating expenses | Prior1YTDDuration | 1545000 | JPY |
| Non operating expenses | CurrentYTDDuration | 3574000 | JPY |
| Ordinary income | Prior1YTDDuration | 205095000 | JPY |
| Ordinary income | CurrentYTDDuration | 194049000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | 1631000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | 2552000 | JPY |
| Extraordinary income | Prior1YTDDuration | 1631000 | JPY |
| Extraordinary income | CurrentYTDDuration | 2552000 | JPY |
| Loss on valuation of investment securities el | Prior1YTDDuration | － | JPY |
| Loss on valuation of investment securities el | CurrentYTDDuration | 4269000 | JPY |
| Extraordinary loss | Prior1YTDDuration | － | JPY |
| Extraordinary loss | CurrentYTDDuration | 4269000 | JPY |
| Income before income taxes | Prior1YTDDuration | 206727000 | JPY |
| Income before income taxes | CurrentYTDDuration | 192331000 | JPY |
| Income taxes current | Prior1YTDDuration | 80287000 | JPY |
| Income taxes current | CurrentYTDDuration | 73629000 | JPY |
| Income taxes deferred | Prior1YTDDuration | -3194000 | JPY |
| Income taxes deferred | CurrentYTDDuration | -7728000 | JPY |
| Income taxes | Prior1YTDDuration | 77092000 | JPY |
| Income taxes | CurrentYTDDuration | 65901000 | JPY |
| Profit loss | Prior1YTDDuration | 129635000 | JPY |
| Profit loss | CurrentYTDDuration | 126430000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | 13421000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | 10658000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 116213000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 115771000 | JPY |
| Profit loss | Prior1YTDDuration | 129635000 | JPY |
| Profit loss | CurrentYTDDuration | 126430000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 3331000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | -1442000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 3331000 | JPY |
| Other comprehensive income | CurrentYTDDuration | -1442000 | JPY |
| Comprehensive income | Prior1YTDDuration | 132966000 | JPY |
| Comprehensive income | CurrentYTDDuration | 124987000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 125215000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 130366000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | 7751000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | -5378000 | JPY |
| Income before income taxes | Prior1YTDDuration | 206727000 | JPY |
| Income before income taxes | CurrentYTDDuration | 192331000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 7833000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 8951000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |